The recent announcement by the Department of Justice (DOJ) that it obtained more than $3 billion in judgments and settlements under the False Claims Act (FCA) in FY 2019 underscores the ongoing enforcement risks companies face in the health care, defense and other industries.

The DOJ’s statistics reflecting its total yearly recoveries under the FCA demonstrate that the department’s civil fraud enforcement efforts continue to be robust, particularly in the health care and life sciences industries, which generated about $2.6 billion of the recoveries last year. Qui tam actions filed by whistleblowers (relators) continue to be the source of most FCA payouts.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]